Antithrombotic Choice After LAAO

Key Result

Post-left atrial appendage occlusion, apixaban use was associated with a significantly lower risk of thromboembolic events compared to other antithrombotics.

Key Points

• To determine the optimal antithrombotic therapy following left atrial appendage occlusion (LAAO) procedures.
• Conducted an observational analysis of patients post-LAAO.
• Compared outcomes of different antithrombotic regimens.
• Assessed bleeding risk and thrombosis rates.
• Identified significant differences in bleeding complications across antithrombotic choices.
• Noticed a trend towards lower thrombosis rates with specific antithrombotic interventions.
• Suggested certain regimens improve clinical outcomes compared to others.